150 related articles for article (PubMed ID: 6393074)
1. Cefonicid: a long-acting, second-generation cephalosporin. Antimicrobial activity, pharmacokinetics, clinical efficacy and adverse effects.
Pontzer RE; Kaye D
Pharmacotherapy; 1984; 4(6):325-33. PubMed ID: 6393074
[TBL] [Abstract][Full Text] [Related]
2. Review of cefonicid, a long-acting cephalosporin.
Dudley MN; Quintiliani R; Nightingale CH
Clin Pharm; 1984; 3(1):23-32. PubMed ID: 6365414
[TBL] [Abstract][Full Text] [Related]
3. Cefonicid: an overview of clinical studies in the United States.
Jacob LS; Layne P
Rev Infect Dis; 1984; 6 Suppl 4():S791-802. PubMed ID: 6395272
[TBL] [Abstract][Full Text] [Related]
4. Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.
Saltiel E; Brogden RN
Drugs; 1986 Sep; 32(3):222-59. PubMed ID: 3530703
[TBL] [Abstract][Full Text] [Related]
5. Treatment of bacterial osteomyelitis and Staphylococcus aureus endocarditis and single-dose therapy for uncomplicated Neisseria gonorrhoeae infections: an overview.
Mader JT; Reinarz JA
Rev Infect Dis; 1984; 6 Suppl 4():S857-64. PubMed ID: 6395277
[TBL] [Abstract][Full Text] [Related]
6. Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.
Campoli-Richards DM; Lackner TE; Monk JP
Drugs; 1987 Oct; 34(4):411-37. PubMed ID: 3315624
[TBL] [Abstract][Full Text] [Related]
7. Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime.
Tartaglione TA; Polk RE
Drug Intell Clin Pharm; 1985 Mar; 19(3):188-98. PubMed ID: 3884304
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cefonicid and cefamandole for the treatment of community-acquired infections of the lower respiratory tract.
Geckler RW; McCormack GD; Goodman JS
Rev Infect Dis; 1984; 6 Suppl 4():S847-52. PubMed ID: 6395275
[TBL] [Abstract][Full Text] [Related]
9. An overview: evaluation of cefonicid in infections of the urinary tract, lower respiratory tract, and skin and soft tissue.
Kaye D
Rev Infect Dis; 1984; 6 Suppl 4():S835-8. PubMed ID: 6522926
[TBL] [Abstract][Full Text] [Related]
10. Use of long half-life parenteral cephalosporins in ambulatory practice.
Sauerwein M; Deamer RL; Prichard JG
J Fam Pract; 1987 Jan; 24(1):47-51. PubMed ID: 3794613
[TBL] [Abstract][Full Text] [Related]
11. Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin.
Mini E; Mazzei T; Periti P; Reali EF; Bordonaro P; Balocchini E; Ninu B
Chemioterapia; 1987 Apr; 6(2):95-8. PubMed ID: 3594635
[TBL] [Abstract][Full Text] [Related]
12. Ceforanide: antibacterial activity, pharmacology, and clinical efficacy.
Barriere SL; Mills J
Pharmacotherapy; 1982; 2(6):322-7. PubMed ID: 6762529
[TBL] [Abstract][Full Text] [Related]
13. [In-vitro activity of cefonicid on hospital bacteria. Regression line and proposal for critical values].
Chanal M; Cluzel M; Sirot D; Joly B; Sirot J; Cluzel R
Pathol Biol (Paris); 1986 May; 34(5):385-9. PubMed ID: 3095773
[TBL] [Abstract][Full Text] [Related]
14. In vitro experience with cefonicid.
Actor P
Rev Infect Dis; 1984; 6 Suppl 4():S783-90. PubMed ID: 6522920
[TBL] [Abstract][Full Text] [Related]
15. A randomized clinical trial comparing the safety and efficacy of cefonicid and cefamandole in the treatment of patients with respiratory tract infections caused by susceptible pathogens.
Azanza JR; Honorato J; Rubio A; Cuena R
Chemioterapia; 1987 Jun; 6(2 Suppl):449-51. PubMed ID: 3334597
[No Abstract] [Full Text] [Related]
16. Cefonicid sodium (Monocid).
Med Lett Drugs Ther; 1984 Aug; 26(667):71-2. PubMed ID: 6379400
[No Abstract] [Full Text] [Related]
17. Role of long-acting cephalosporins in ambulatory therapy.
Prichard JG
Clin Ther; 1988; 10(6):688-93. PubMed ID: 3219684
[TBL] [Abstract][Full Text] [Related]
18. [Update on antibiotic therapy. 30) Cefonicid].
di Nola F
Minerva Med; 1985 Apr; 76(16):819-25. PubMed ID: 4000526
[No Abstract] [Full Text] [Related]
19. Clinical efficacy of cefonicid in the treatment of staphylococcal infections.
Lentnek AL; Evrard HM; Wikler MA; Sohn CA; Phillips SW
Clin Ther; 1985; 7(6):725-32. PubMed ID: 4075363
[TBL] [Abstract][Full Text] [Related]
20. Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus.
Chambers HF; Mills J; Drake TA; Sande MA
Rev Infect Dis; 1984; 6 Suppl 4():S870-4. PubMed ID: 6522927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
